A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.

Fabio Salvatore MacalusoMarco VentimigliaWalter FriesAnna ViolaAldo SitibondoMaria CappelloBarbara ScrivoAnita BusaccaAntonino Carlo PriviteraSalvatore CamilleriSerena GarufiRoberto Di MitriFilippo MocciaroNunzio BelluardoEmiliano GiangrecoCarmelo BertolamiSara RennaRosalba OrlandoGiulia RizzutoMario CottoneAmbrogio Orlandonull null

Published in: Journal of gastroenterology and hepatology (2020)

In the first study comparing VDZ and ADA in CD via propensity score analysis, the drugs showed comparable effectiveness and a similar safety profile.

Keyphrases

ulcerative colitis
rheumatoid arthritis
randomized controlled trial
systematic review
magnetic resonance
magnetic resonance imaging
juvenile idiopathic arthritis
contrast enhanced
computed tomography
systemic lupus erythematosus
drug induced
disease activity